Latest Insider Transactions at Cvs Health Corp (CVS)
This section provides a real-time view of insider transactions for Cvs Health Corp (CVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CVS HEALTH Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CVS HEALTH Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 01
2015
|
C David Brown Ii Director |
SELL
Open market or private sale
|
Direct |
15,000
-12.9%
|
$1,500,000
$100.27 P/Share
|
|
Apr 10
2015
|
Andrew Sussman EVP, Clinical Services |
SELL
Open market or private sale
|
Direct |
17,638
-32.83%
|
$1,799,076
$102.38 P/Share
|
|
Apr 10
2015
|
Andrew Sussman EVP, Clinical Services |
BUY
Exercise of conversion of derivative security
|
Direct |
12,556
+23.67%
|
$615,244
$49.8 P/Share
|
|
Apr 02
2015
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,862
-6.05%
|
$189,924
$102.71 P/Share
|
|
Apr 02
2015
|
Andrew Sussman EVP, Clinical Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,596
-10.27%
|
$162,792
$102.71 P/Share
|
|
Apr 02
2015
|
Helena Foulkes EVP & President-CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,394
-7.31%
|
$244,188
$102.71 P/Share
|
|
Apr 02
2015
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
19,944
-10.99%
|
$2,034,288
$102.71 P/Share
|
|
Apr 02
2015
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,654
-8.2%
|
$474,708
$102.71 P/Share
|
|
Apr 02
2015
|
David M Denton EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,648
-5.59%
|
$678,096
$102.71 P/Share
|
|
Apr 02
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,637
-21.2%
|
$1,696,974
$102.71 P/Share
|
|
Apr 02
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,637
+17.49%
|
$748,665
$45.07 P/Share
|
|
Apr 02
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,989
-6.06%
|
$406,878
$102.71 P/Share
|
|
Apr 02
2015
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,862
-3.15%
|
$189,924
$102.71 P/Share
|
|
Apr 01
2015
|
Stephen J Gold EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
5,867
+13.56%
|
$598,434
$102.26 P/Share
|
|
Apr 01
2015
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,889
+15.33%
|
$498,678
$102.26 P/Share
|
|
Apr 01
2015
|
Andrew Sussman EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct |
3,422
+16.79%
|
$349,044
$102.26 P/Share
|
|
Apr 01
2015
|
Andrew Sussman EVP, Clinical Services |
SELL
Payment of exercise price or tax liability
|
Direct |
3,086
-20.17%
|
$314,772
$102.26 P/Share
|
|
Apr 01
2015
|
Helena Foulkes EVP & President-CVS Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct |
8,556
+16.71%
|
$872,712
$102.26 P/Share
|
|
Apr 01
2015
|
Larry J Merlo Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,115
+14.01%
|
$3,989,730
$102.26 P/Share
|
|
Apr 01
2015
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,778
+14.27%
|
$997,356
$102.26 P/Share
|
|
Apr 01
2015
|
David M Denton EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
8,556
+4.63%
|
$872,712
$102.26 P/Share
|
|
Apr 01
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,845
+13.5%
|
$698,190
$102.26 P/Share
|
|
Apr 01
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,747
-22.55%
|
$1,708,194
$102.26 P/Share
|
|
Apr 01
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,747
+18.4%
|
$569,398
$34.96 P/Share
|
|
Apr 01
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,234
-3.74%
|
$227,868
$102.26 P/Share
|
|
Apr 01
2015
|
J. David Joyner President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,422
+16.43%
|
$349,044
$102.26 P/Share
|
|
Apr 01
2015
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,801
-3.19%
|
$183,702
$102.26 P/Share
|
|
Apr 01
2015
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,911
+14.6%
|
$398,922
$102.26 P/Share
|
|
Apr 01
2015
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,029
-4.14%
|
$104,958
$102.26 P/Share
|
|
Apr 01
2015
|
Thomas M Moriarty EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
7,334
+20.25%
|
$748,068
$102.26 P/Share
|
|
Mar 23
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
33,274
-37.66%
|
$3,460,496
$104.94 P/Share
|
|
Mar 23
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,274
+27.36%
|
$1,497,330
$45.07 P/Share
|
|
Mar 20
2015
|
C David Brown Ii Director |
SELL
Open market or private sale
|
Direct |
25,000
-17.7%
|
$2,600,000
$104.3 P/Share
|
|
Mar 02
2015
|
Larry J Merlo Director |
SELL
Bona fide gift
|
Direct |
2,419
-1.7%
|
$251,576
$104.19 P/Share
|
|
Mar 02
2015
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
98
-0.21%
|
$10,192
$104.19 P/Share
|
|
Feb 27
2015
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,720
+7.53%
|
$177,160
$103.87 P/Share
|
|
Feb 27
2015
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,406
+9.58%
|
$247,818
$103.87 P/Share
|
|
Feb 27
2015
|
Larry J Merlo Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,188
+31.74%
|
$6,817,364
$103.87 P/Share
|
|
Feb 27
2015
|
David M Denton EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
18,051
+14.67%
|
$1,859,253
$103.87 P/Share
|
|
Feb 27
2015
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,644
+24.92%
|
$1,611,332
$103.87 P/Share
|
|
Feb 27
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,839
+20.08%
|
$1,425,417
$103.87 P/Share
|
|
Feb 27
2015
|
Helena Foulkes EVP & President-CVS Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct |
9,627
+25.74%
|
$991,581
$103.87 P/Share
|
|
Feb 27
2015
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,627
+26.35%
|
$991,581
$103.87 P/Share
|
|
Feb 27
2015
|
J. David Joyner President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,017
+10.35%
|
$619,751
$103.87 P/Share
|
|
Feb 27
2015
|
Andrew Sussman EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct |
6,017
+40.44%
|
$619,751
$103.87 P/Share
|
|
Feb 27
2015
|
Thomas M Moriarty EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,768
+50.0%
|
$697,104
$103.87 P/Share
|
|
Feb 27
2015
|
Thomas M Moriarty EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,257
+20.03%
|
$232,471
$103.87 P/Share
|
|
Feb 27
2015
|
Stephen J Gold EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
6,991
+50.0%
|
$720,073
$103.87 P/Share
|
|
Feb 27
2015
|
Stephen J Gold EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
1,432
+10.74%
|
$147,496
$103.87 P/Share
|
|
Feb 19
2015
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
460
-2.22%
|
$46,920
$102.62 P/Share
|